A carregar...
Targeting Immune System Alterations in Hodgkin Lymphoma
PURPOSE OF REVIEW: This review discusses novel immunotherapeutic approaches to treat Hodgkin lymphoma (HL), specifically PD-1 inhibitors and cellular immunotherapy. RECENT FINDINGS: PD-1 inhibitors have shown promising results in the treatment of relapsed or refractory HL, leading to FDA approval of...
Na minha lista:
| Publicado no: | Curr Hematol Malig Rep |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7593851/ https://ncbi.nlm.nih.gov/pubmed/28780614 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1007/s11899-017-0398-6 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|